Clonal compositions involving epigenetic regulator and splicing mutations in CHIP, CCUS, MDS, and CMML-Reference-Cited by-同舟云学术

Clonal compositions involving epigenetic regulator and splicing mutations in CHIP, CCUS, MDS, and CMML

Published:2022-05 Issue: Volume:116 Page:106818
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Xie Zhuoer,Campestri Gina,Lasho Terra,Finke Christy,Li Marissa,Binder Moritz,Fernandez Jenna,Olteanu Horatiu,Reichard Kaaren K.,Ketterling Rhett,Litzow Mark,Tefferi Ayalew,Mangaonkar Abhishek,Gangat Naseema,Al-Kali Aref,Patnaik Mrinal M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference22 articles.

1. The evolutionary dynamics and fitness landscape of clonal hematopoiesis;Watson;Science,2020

2. Large-scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers;Feusier;Blood Cancer Discov.,2021

3. Clonal hematopoiesis and non-hematologic disorders;Jaiswal;Blood,2020

4. CHIP, CCUS, and other acronyms: definition, implications, and impact on practice;DeZern;Am. Soc. Clin. Oncol. Educ. B,2019

5. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes;Steensma;Blood,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of CMML patients undergoing allo‐HCT are significantly worse compared to MDS—a study of the CMWP of the EBMT;American Journal of Hematology;2023-11-27

2. Evolution of clonal hematopoiesis;Clinical and Translational Medicine;2023-10

3. Single cell proteogenomic analysis of aberrant monocytosis in TET2 mutant premalignant and malignant hematopoiesis;Leukemia;2023-03-25

4. A Lower Frequency of Spliceosome Mutations Distinguishes Clonal Cytopenias of Undetermined Significance From Low-Risk Myelodysplastic Syndromes, Despite Inherent Similarities in Genomic, Laboratory, and Clinical Features;Modern Pathology;2023-03

5. Clinical and molecular spectrum and prognostic outcomes of U2AF1 mutant clonal hematopoiesis- a prospective mayo clinic cohort study;Leukemia Research;2023-02